Autopsy report · NCT01506960
Evaluation of a Combined Near Infrared Spectroscopy (NIRS) and Intravascular Ultrasound (IVUS) Catheter for Detection of Lipid Rich Plaque
Cause of deathSlow enrollment
“It was felt that a sufficient number of subjects were enrolled.”
Life of this trial
- Ran for about 5 months before it stopped.
- 64 participants enrolled.
- Results were posted on the registry 1 year 4 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Coronary Artery Disease
- Interventions
- InfraReDx Lipiscan IVUS
- Participants
- 64
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Safety Study of Autologous Cultured Adipose -Derived Stem Cells for the Fecal Incontinence
“Few subject enrolled” - Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order
“Required number of subjects to be included could not be accomplished” - Nephrotoxicity of Iopamidol Versus Iodixanol in High-Risk Patients
“There were few eligible subjects from other centers.” - Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension
“Failure to enroll a suitable number of qualified subjects.” - A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
“Three subjects were enrolled and all three subjects withdrew.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.